1. BIOM-22. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AS A MOLECULAR DETERMINANT OF GLIOBLASTOMA RESPONSE TO DOPAMINE RECEPTOR 2 (DRD2) INHIBITORS. (9th November 2020) Authors: He, Yuyu; Li, Jie; Koga, Tomoyuki; Ma, Jun; Dhawan, Sanjay; Suzuki, Yuta; Furnari, Frank; Prabhu, Varun; Allen, Joshua; Chen, Clark Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CADD-21. PROTEASOME INHIBITION IS A TARGETED THERAPY FOR PTEN-DEFICIENT GLIOBLASTOMAS. (5th November 2018) Authors: Benitez, Jorge; Finlay, Darren; Ma, Jianhui; Koga, Tomoyuki; Vuori, Kristiina; Furnari, Frank Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CSIG-10. GENOTYPE – KINOME GUIDED DEVELOPMENT OF PRECISION EGFR-TARGETED THERAPEUTICS FOR GLIOBLASTOMA. (9th November 2020) Authors: Smithberger, Erin; Shelton, Abigail; Butler, Madison; Stamper, Allie; Bash, Ryan; Angus, Steven; East, Michael; Johnson, Gary; Berens, Michael; Furnari, Frank; Miller, C Ryan Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CSIG-14. PTEN AS A SIGNATURE OF VULNERABILITY OF GBM TO NEDDYLATION INHIBITION. (12th November 2021) Authors: Taylor, Brett; Ferdosi, Shayesteh; Lee, Matthew; Tang, Nanyun; Peng, Sen; Bybee, Rita; Hartman, Lauren; Reid, George; Garcia-Mansfield, Krystine; Sharma, Ritin; Pirrotte, Patrick; Ma, Jianhui; Parisian, Alison; Furnari, Frank; Dhruv, Harshil; Berens, Michael Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CSIG-25. EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR DOMAIN MISSENSE MUTATION A289V AS A DRIVER OF GLIOBLASTOMA INVASION AND PROLIFERATION. (5th November 2018) Authors: Binder, Zev; Thorne, Amy; Bakas, Spyridon; Wileyto, E Paul; Akbari, Hamed; Rathore, Saima; Min Ha, Sung; Zhang, Logan; Idbaih, Ahmed; Bagley, Stephen; Morrissette, Jennifer; Nasrallah, MacLean; Ma, Jianhui; Zanca, Ciro; Scott, Andrew; Davatzikos, Christos; Furnari, Frank; O'Rourke, Donald Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. DDIS-24. PROTEASOME INHIBITION IS A TARGETED THERAPY FOR PTEN-DEFICIENT GLIOBLASTOMAS. (5th November 2018) Authors: Benitez, Jorge; Finlay, Darren; Ma, Jianhui; Koga, Tomoyuki; Vuori, Kristiina; Furnari, Frank Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. DDRE-24. ACQUIRED RESISTANCE TO TARGETED INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMA: IDENTIFICATION OF DUAL KINASE TARGETS. (9th November 2020) Authors: Shelton, Abigail; Smithberger, Erin; Butler, Madison; Stamper, Allie; Bash, Ryan; Angus, Steven; East, Mike; Johnson, Gary; Berens, Michael; Furnari, Frank; Miller, C Ryan Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DRES-07. DEFINING THE MECHANISMS OF ACQUIRED RESISTANCE TO TYROSINE KINASE INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMAS USING INTEGRATED KINOME AND TRANSCRIPTOME PROFILING. (5th November 2018) Authors: Shelton, Abigail; Smithberger, Erin; Butler, Madison; Flores, Alex; Bash, Ryan; Angus, Steven; Sciaky, Noah; Dhruv, Harshil; Johnson, Gary; Berens, Michael; Furnari, Frank; Miller, Ryan Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DRES-13. DUAL KINASE INHIBITION TO COMBAT EGFR-INHIBITOR RESISTANCE IN GLIOBLASTOMA. (11th November 2019) Authors: Smithberger, Erin; Shelton, Abigail; Butler, Madison; Flores, Alex; Bash, Ryan; Angus, Steven; East, Michael; Sciaky, Noah; Dhruv, Harshil; Johnson, Gary; Berens, Michael; Furnari, Frank; Ryan Miller, C Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors. Issue 3 (24th August 2020) Authors: He, Yuyu; Li, Jie; Koga, Tomoyuki; Ma, Jun; Dhawan, Sanjay; Suzuki, Yuta; Furnari, Frank; Prabhu, Varun V; Allen, Joshua E; Chen, Clark C Journal: Neuro-oncology Issue: Volume 23:Issue 3(2021) Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗